Tomorrow at 1pm ET: How Can Fintech Make it Easier for Early Stage Life Science Companies to Grow? [From our Partner]

Register for this May 8th webinar exploring how early stage life science investors are sizing up the market.

View in browser How Can Fintech Make it Easier for Early Stage Life Science Companies to Grow? The federal government's funding cutbacks and NIH and other departments are anticipated to hit early stage companies the hardest. This is creating new opportunities for companies and alternative funding sources to fill the gap.   Register now to join us on May 8 at 1pm ET for a compelling discussion on early stage life science trends led by a group of investors. The webinar, sponsored by fintech business Mercury, will focus on how they are advising startups, the developments they are seeing, from emerging tech trends, the role of accelerators, the impact of AI, and their outlook. Register Now If you cannot attend the live event, please register as you will be eligible to receive an on-demand recording of this event. Mercury is a financial technology company, not a bank.  Banking services provided by Choice Financial Group, Column N.A., and Evolve Bank & Trust, Members FDIC. MedCity News, PO Box 901, New York, NY 10272, United States, 2123341871 Unsubscribe Manage preferences